Parametric Portfolio Associates’s Precision BioSciences DTIL Stock Holding History

Parametric Portfolio Associates’s Portfolio DTIL Stock Details DTIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$194K	Sell	2,098 -714	-25%	-$97K	﹤0.01%	3451
2021 Q4	$624K	Buy	2,812 +641	+30%	+$179K	﹤0.01%	2970
2021 Q3	$751K	Sell	2,171 -181	-8%	-$61.3K	﹤0.01%	2926
2021 Q2	$883K	Sell	2,352 -368	-14%	-$111K	﹤0.01%	2826
2021 Q1	$845K	Buy	2,720 +798	+42%	+$279K	﹤0.01%	3241
2020 Q4	$481K	Buy	1,922 +240	+14%	+$58.8K	﹤0.01%	3402
2020 Q3	$311K	Sell	1,682 -368	-18%	-$73.2K	﹤0.01%	3469
2020 Q2	$512K	Buy	2,050 +899	+78%	+$197K	﹤0.01%	3265
2020 Q1	$208K	Sell	1,151 -230	-17%	-$60.2K	﹤0.01%	3536
2019 Q4	$576K	Buy	1,381 +313	+29%	+$98.3K	﹤0.01%	3312
2019 Q3	$269K	Sell	1,068 -95	-8%	-$30.9K	﹤0.01%	3592
2019 Q2	$462K	Buy	1,163 +750	+182%	+$302K	﹤0.01%	3394
2019 Q1	$223K	Buy	+413	New	+$219K	﹤0.01%	3675

Other funds holding DTIL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

OMC

OUP Management Company Bala Cynwyd, Pennsylvania $44.5M AUM 55.11% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Parametric Portfolio Associates's DTIL Position: Q1 2022 in Review

Parametric Portfolio Associates reduced its Precision BioSciences (DTIL) stake by 25% in Q1 2022, selling an estimated $97K and leaving 2,098 shares worth $194K. The position accounts for ﹤0.01% of the portfolio, ranked #3451.

Parametric Portfolio Associates first reported a position in DTIL in Q1 2019 and has held it in 13 quarters since. The position peaked at $883K in Q2 2021. 152 funds tracked by Wall St. Rank hold DTIL as of Q1 2022.

Parametric Portfolio Associates held 2,098 shares of Precision BioSciences worth $194K as of Q1 2022.
Parametric Portfolio Associates sold 714 Precision BioSciences shares in Q1 2022, an estimated $97K.
Precision BioSciences made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #3451 holding.
Parametric Portfolio Associates first reported a position in Precision BioSciences in Q1 2019 and has held it in 13 quarters since.
Parametric Portfolio Associates's Precision BioSciences position peaked at $883K in Q2 2021.
152 funds tracked by Wall St. Rank held Precision BioSciences as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.